ProductsIsraeli Entrepreneurs’ Terpenes Plans For UK

Israeli Entrepreneurs’ Terpenes Plans For UK

-

TWO Israeli businessmen with strong UK links have joined forces to deliver high-quality cannabis terpenes to European consumers.

CiiTech, a leading cannabis business, has partnered with Kanabo Research to launch terpene formulas for use with the latter’s VapePod.

In a press release the partners say they will use CiiTech’s ‘terpene formulas to meet the highest standards required for the UK market’.

These have been designed specifically for use with the VapePod, Kanabo’s patented device which was the first to be approved for medical use by the Israeli Ministry of Health. 

Terpenes are essential plant oils that deliver distinctive flavors and smells and include the likes of linalool – also present in lavender –  and pinene, in conifers.

They also confer therapeutic effects, with cannabis terpenes being used to promote sleep, fight inflammation and boost mood.

CiiTech was was founded by Clifton Flack, once of  iCAN and the investment platform CannaTech. 

The London-based company initiates in-house research and created Provocan which has been selected as best in class among UK CBD brands.

He said trust in CBD brands is ‘crucial’ and collaboration with partners such as Kanabo can help achieve that.

He added: “There’s a real growth in consumer understanding of the terpenes. 

“We believe our proven formulas created with Kanabo for the VapePod device deliver an exceptional level of CBD innovation and efficacy not previously seen in the industry.”

Kanabo plans to list on the London Stock Exchange in what will be an effective reverse takeover with UK shell company Spinnaker Opportunities PLC.


Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

1 COMMENT

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Industry Concerns Surface Over No 10 Taskforce’s Hemp And Cannabis Proposals

THE initial warm welcome to proposals to make UK cannabinoid regulations a matter for the health authorities - not...

IM Cannabis Clinical Survey Confirms Effectiveness of Proprietary Strains in Alleviating Symptoms of Seven Key Health Conditions

IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC, CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational...

Always Pure Organics Makes £3m Continental Swoop For Leading B2C Hemp And CBD Player

FAST-GROWING UK cannabis wholesaler Always Pure Organics has acquired two Belgian companies - Distribution Legal Hemp and NexGen -...

Little Green Pharma Picks Up Distressed Canadian LP’s Danish Cannabis Asset for £11.6m

AUSTRALIAN company Little Green Pharma has purchased the former Canopy Growth medicinal cannabis cultivation and manufacturing facility in Denmark...

New Era Beckons For Swiss Medical Cannabis Patients After Ten Years In Slow Lane

THE impending change to Switzerland’s medical cannabis laws could see the number of patients receiving treatment rise from 3,000...

How Britain’s Three Crown Dependencies Are Stealing A Cannabis March On the Mainland

FRUSTRATED by the UK Government’s stance the three UK Crown Dependencies of Jersey, Guernsey and the Isle of Man,...

Must read

Industry Concerns Surface Over No 10 Taskforce’s Hemp And Cannabis Proposals

THE initial warm welcome to proposals to make UK...

Little Green Pharma Picks Up Distressed Canadian LP’s Danish Cannabis Asset for £11.6m

AUSTRALIAN company Little Green Pharma has purchased the former...

You might also likeRELATED
Recommended to you